Analysts’ new coverage for Thursday, September 14th:

Royal Bank Of Canada initiated coverage on shares of Abeona Therapeutics (NASDAQ:ABEO). The firm issued an outperform rating on the stock.

Royal Bank Of Canada started coverage on shares of Agios Pharmaceuticals (NASDAQ:AGIO). They issued an outperform rating on the stock.

Royal Bank Of Canada initiated coverage on shares of Akebia Therapeutics (NASDAQ:AKBA). They issued a sector perform rating on the stock.

Royal Bank Of Canada assumed coverage on shares of Alexion Pharmaceuticals (NASDAQ:ALXN). The firm issued an outperform rating on the stock.

Royal Bank Of Canada assumed coverage on shares of Amgen (NASDAQ:AMGN). Royal Bank Of Canada issued a sector perform rating on the stock.

Royal Bank Of Canada began coverage on shares of Athenex (NASDAQ:ATNX). The firm issued an outperform rating on the stock.

Royal Bank Of Canada assumed coverage on shares of Clovis Oncology (NASDAQ:CLVS). The firm issued a sector perform rating on the stock.

Royal Bank Of Canada initiated coverage on shares of Exelixis (NASDAQ:EXEL). Royal Bank Of Canada issued an outperform rating on the stock.

Royal Bank Of Canada initiated coverage on shares of Gilead Sciences (NASDAQ:GILD). The firm issued an outperform rating on the stock.

Royal Bank Of Canada began coverage on shares of Incyte Corporation (NASDAQ:INCY). Royal Bank Of Canada issued a sector perform rating on the stock.

Royal Bank Of Canada assumed coverage on shares of Karyopharm Therapeutics (NASDAQ:KPTI). The firm issued an outperform rating on the stock.

Royal Bank Of Canada assumed coverage on shares of Merus N.V. (NASDAQ:MRUS). The firm issued an outperform rating on the stock.

Royal Bank Of Canada started coverage on shares of Spark Therapeutics (NASDAQ:ONCE). They issued an outperform rating on the stock.

Royal Bank Of Canada started coverage on shares of Ra Pharmctl (NASDAQ:RARX). Royal Bank Of Canada issued an outperform rating on the stock.

Royal Bank Of Canada assumed coverage on shares of Regeneron Pharmaceuticals (NASDAQ:REGN). Royal Bank Of Canada issued a sector perform rating on the stock.

Royal Bank Of Canada started coverage on shares of Seattle Genetics (NASDAQ:SGEN). Royal Bank Of Canada issued an outperform rating on the stock.

Royal Bank Of Canada assumed coverage on shares of TESARO (NASDAQ:TSRO). They issued a sector perform rating on the stock.

Royal Bank Of Canada began coverage on shares of Vertex Pharmaceuticals (NASDAQ:VRTX). They issued an outperform rating on the stock.

Receive News & Ratings for Abeona Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abeona Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.